2019, Number 5
Next >>
Rev Mex Oftalmol 2019; 93 (5)
Keratoconus in pediatric age: clinical-refractive characteristics and evolution. Donum Foundation Medical Specialties Center. Cuenca. Ecuador. 2015-2018
Rojas-Álvarez E
Language: Spanish
References: 46
Page: 221-232
PDF size: 171.35 Kb.
ABSTRACT
Objective: To describe the clinical-refractive characteristics of KC patients at pediatric age and their evolution, at the Donum
Foundation Medical Center, Cuenca, Ecuador.
Method: An observational, prospective and longitudinal study was carried out
in 94 pediatric patients (188 eyes) diagnosed with KC, diagnosed in 2015 and followed up to 2018, in the Donum Foundation
Medical Center, Cuenca, Ecuador. The arithmetic mean of the sample was obtained: mean keratometry, pachymetry at the thinnest point and refractive cylinder, at two moments. The analysis of variance (ANOVA) of repeated measures was used for
a factor with confidence interval adjustment by Bonferroni and p value.
Results: A statistically significant increase was obtained
between the mean value of average keratometry of the sample (49.6 D), at the time of diagnosis, and the mean value
of average keratometry at 3 years of follow-up (52.4 D). (p = 0.02; α = 0.05), a statistically significant decrease between the
average pachymetry of the sample, at the time of diagnosis (482 µm), and the average pachymetry of the sample, at 3 years
of follow-up (459 µm) (p = 0.03; α = 0.05) A statistically significant increase was obtained between the average refractive
cylinder of the sample, at the time of diagnosis (4.6 D), and the average refractive cylinder of the sample, at 3 years of follow-
up (5.1 D) (p = 0.01; α = 0.05).
Conclusions: The modifications of keratometry, refractive cylinder and pachymetry suggest
progression of the disease in this age group, in a period of 3 years.
REFERENCES
Kankariya VP, Kymionis GD, Diakonis VF, Yoo SH. Management of pediatric keratoconus – Evolving role of corneal collagen cross-linking: An update. Indian J Ophthalmol. 2013;61(8):435-40.
Galvis V, Sherwin T, Tello A, Merayo J, Barrera R, Acera A. Keratoconus: an inflammatory disorder? Eye. 2015;29:843-59.
Konstantopoulos A, Mehta JS. Conventional versus accelerated collagen cross- linking for keratoconus. Eye Contact Lens. 2015;41(2):65-7.
Mastropasqua L. Collagen cross-linking: When and how? A review of the state of the art of the technique and new perspectives. Eye Vis (Lond). 2015;2:19.
Soiberman U, Foster JW, Jun AS, Chakravarti S. Pathophysiology of Keratoconus: What Do We Know Today. Open Ophthalmol J. 2017; 11:252‑61.
Hammer A, Richoz O, Arba Mosquera S, Tabibian D, Hoogewoud F, Hafezi F. Corneal biomechanical properties at different corneal cross-linking (CXL) irradiances. Invest Ophthalmol Vis Sci. 2014;55(5):2881-4.
Soeters N, van der Valk R, Tahzib NG. Corneal cross-linking for treatment of progressive keratoconus in various age groups. J Refract Surg. 2014; 30(7):454-60.
El Rami H, Chelala E, Dirani A, Fadlallah A, Fakhoury H, Cherfan C, et al. An Update on the Safety and Efficacy of Corneal Collagen Cross-Linking in PediatricKeratoconus. Biomed Res Int. 2015;2015:257‑927.
Abril LE. Estudio topográfico de pacientes diagnosticados con queratocono en la costa y sierra ecuatoriana en el periodo agosto 2014 a enero 2015. Tesis. Instituto Tecnológico Cordillera. Ecuador. 2015.
Mansfield N. El queratocono en pacientes de una institución privada de la ciudad de Quito, en el periodo de enero de 2015 a octubre de 2016. Tesis. Universidad de los Andes. Ecuador. 2017.
Reynoso MF, Castañeda GF. Diagnóstico y características del queratocono por topografía corneal en el Hospital Santa Inés Cuenca, 2012-2014 [tesis]. Universidad de Cuenca, Ecuador; 2016.
Marrero E, Sánchez O, Barrera BR, Díaz S, Somoza JA. Caracterización de pacientes con queratocono. Rev MEDISAN. 2011;15(12):1698-704.
Refik O, Gunhal S, Meryem D, Mehmet K, Hurkan K, Mehmet O, et al. Six-month outcomes of corneal crosslinking with dextran-free isotonic riboflavin solution. Arq Bras Oftalmol. 2016;79(3):147-50.
Kaya V, Utine CA, Yılmaz ÖF. Intraoperative corneal thickness measurements during corneal collagen cross-linking with hypoosmolar riboflavin solution in thin corneas. Cornea. 2012;31(5):486-90.
Vinciguerra P, Randleman JB, Romano V, Legrottaglie EF, Rosetta P, Camesasca FI, Piscopo R, Azzolini C, Vinciguerra R. Transepithelial iontophoresis corneal collagen cross-linking for progressive keratoconus: initial clinical outcomes. J Refract Sur. 2014;30(11):746-53.
Buzzonetti L, Petrocelli G, Valente P, Iarossi G, Ardia R, Petroni S. Iontophoretic transepithelial corneal cross-linking to halt keratoconus in pediatric cases: 15-month follow-up. Cornea. 2015;34(5):512-5.
Magli A, Chiariello Vecchio E, Carelli R, Piozzi E, Di Landro F, Troisi S. Pediatric keratoconus and iontophoretic corneal crosslinking: refractive and topographic evidence in patients underwent general and topical anesthesia, 18 months of follow-up. Int Ophthalmol. 2016;36(4):585-90.
Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-a-reduced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003;135(5):620-7.
Jian W, Shen Y, Chen Y, Tian M, Zhou X. Ocular dimensions of the Chinese adolescents with keratoconus. BMC Ophthalmol. 2018;18(1):43.
Léoni-Mesplié S, Mortemousque B, Touboul D, Malet F, Praud D, Mesplié N, et al. Scalability and severity of keratoconus in children. Am J Ophthalmol. 2012;154:56-62.
Ucakhan OO, Bayraktutar BN, Saglik A. Pediatric corneal collagen cross-linking: long-term follow-up of visual, refractive, and topographic outcomes. Cornea. 2016;35:162-8.
Kankariya VP, Kymionis GD, Diakonis VF, Yoo SH. Management of pediatric keratoconus-evolving role of corneal collagen cross-linking: an update. Indian J Ophthalmol. 2013;61(8):435-40.
Godefrooij DA, de Wit GA, Uiterwaal CS, Imhof SM, Wisse RPL. Age-specific incidence and prevalence of keratoconus: a nationwide registration study. American Journal of Ophthalmology. 2017;175:169-72.
Agrawal V. Long-term results of cornea collagen cross-linking with riboflavin for keratoconus. Indian J Ophthalmol. 2013;61(8):433-4.
Pérez Z, Ulloa S, Escalona E, Castillo A, Márquez S. Caracterización clínica y epidemiológica del queratocono. Rev Cubana Oftalmol. 2014;27(4).
Ertan A, Muftuoglu O. Keratoconus clinical findings according to different age and gender groups. Cornea. 2008;27:1109-13.
Kamiya K, Shimizu K, Igarashi A, Miyake T. Assessment of anterior, posterior, and total central corneal astigmatism in eyes with keratoconus. Am J Ophthal. 2015;160(5):851-7.
Feizi S, Delfazayebaher S, Javadi MA, Karimian F, Ownagh V, Sadeghpour F. Mean Posterior Corneal Power and Astigmatism in Normal versus Keratoconic Eyes. J Ophthalmic Vis Res. 2018;13(2):93-100.
Shajari M, Friderich S, Pour Sadeghian M, Schmack I, Kohnen T. Characteristics of Corneal Astigmatism of Anterior and Posterior Surface in a Normal Control Group and Patients With Keratoconus. Cornea. 2017; 36:457-62.
Savini G, Næser K, Schiano-Lomoriello D, Mularoni A. Influence of Posterior Corneal Astigmatism on Total Corneal Astigmatism in Eyes With Keratoconus. Cornea. 2016;35:1427-33.
Naderan M, Rajabi MT, Zarrinbakhsh P. Distribution of Anterior and Posterior Corneal Astigmatism in Eyes With Keratoconus. Am J Ophthalmol. 2016;167:79-87.
Reddy JC, Rapuano CJ, Cater JR, Suri K, Nagra PK, Hammersmith KM. Comparative evaluation of dual Scheimpflug imaging parameters in keratoconus, early keratoconus, and normal eyes. J Cataract Refract Surg. 2014;40:582-92.
Kamiya K, Ishii R, Shimizu K, Igarashi A. Evaluation of corneal elevation, pachymetry and keratometry in keratoconic eyes with respect to the stage of Amsler-Krumeich classification. Br J Ophthalmol. 2014;98:459‑63.
Bernal N, Arias A, Ortega L, Cuevas J. Utilidad de la tomografía corneal pentacam en el queratocono en niños. Oftalmol Clin Exp. 2011;5(1):18‑27.
Alfonso JF, Lisa C, Fernández-Vega Cueto L, Poo A, Madrid D. Clasificación del queratocono basada en fenotipos clínicos. Influencia del astigmatismo congénito en la morfología del queratocono. Biomecánica y arquitectura corneal. 2014;165-84.
Lisa Fernández C. Corrección del queratocono con segmentos intracorneales tipo Ferrara: estrategia personalizada para su implante [tesis doctoral]. Universidad de Oviedo; 2017.
Kamiya K, Shimizu K, Ohmoto F. Effect of aging on corneal biomechanical parameters using the ocular response analyzer. J Refract Surg. 2009;25:888-93.
Takahashi M, Kamiya K, Kono Y, Shoji N. Time Course of Changes in Simulated Keratometry and Total Corneal Refractive Power after Corneal Collagen Cross-Linking for Progressive Keratoconus. Biomed Res Int. 2018;2620784.
Li X, Yang H, Rabinowitz YS. Longitudinal study of keratoconus progression. Exp Eye Res. 2007;85:502-7.
Reeves SW, Stinnett S, Adelman RA, Afshari NA. Risk factors for progression to penetrating keratoplasty in patients with keratoconus. Am J Ophthalmol. 2005;140:607-11.
Plazzi F, Amaral A, Gambi L, Pinheiro L, Amaral B. Corneal collagen cross-linking for progressive keratoconus in patients aged 9 to 14. Rev Bras Oftalmol. 2016;75(2):84-8
Rabinowitz YS. Keratoconus. Surv Ophthalmol. 1998;42:297-319.
Chatzis N, Hafezi F. Progression of keratoconus and efficacy of pediatric [corrected] corneal collagen cross-linking in children and adolescents. J Refract Surg. 2012;28:753-8.
Al Suhaibani AH, Al-Rajhi AA, Al-Motowa S, Wagoner MD. Inverse relationship between age and severity and sequelae of acute corneal hydrops associated with keratoconus. Br J Ophthalmol. 2007;91:984-5.
Nasrin F, Iyer RV, Mathews SM. Simultaneous Estimation of Corneal Topography, Pachymetry, and Curvature. IEEE Trans Med Imaging. 2018;37(11):2463-73.
Or L, Rozenberg A, Abulafia A, Avni I, Zadok D. Corneal Cross-Linking in Pediatric Patients: Evaluating Treated and Untreated Eyes-5-Year Follow-Up Results. Cornea. 2018;37(8):1013-7.